Quantcast

Latest treatment-resistant depression Stories

2014-08-13 12:28:00

Despite Expanding Generic Availability, Opportunity Remains for New Therapies, Particularly for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug. 13, 2014 /PRNewswire/ -- Decision Resources Group finds that in the unipolar depression* market, the expanding use of two recently approved therapies--Lundbeck/Takeda Pharmaceutical's Brintellix (vortioxetine), Actavis (formerly Forest Laboratories)/Pierre Fabre's Fetzima (levomilnacipran...

2014-06-23 12:29:42

Data Highlight Physician and Payer Receptivity to Emerging Agents for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., June 23, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. psychiatrists are receptive to novel adjunctive therapies to antidepressants for treatment-resistant depression (TRD) and would prescribe Otsuka/Lundbeck's emerging atypical antipsychotic brexpiprazole to a mean 12 percent of their drug-treated...

2013-10-24 23:32:21

One of the most advanced, non-invasive, researched and non-drug treatments for people living with chronic and treatment resistant depression is now in Austin, Texas. Texas TMS Center patients now have an opportunity to receive one of the most promising treatments for depression that is FDA-cleared, Brainsway® Deep TMS Therapy. Austin, Texas (PRWEB) October 24, 2013 Texas TMS Center, Austin, Texas, is proud to be one of the first in the United States to offer the breakthrough...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'